GlassScriptPhysician profile
Thomas R Elsass
NPI 1821212986
$582.41
in general payments reported to CMS, 2019-2025
11 companies · $250 in 2025
The $250 reported for 2025 was more than what 84% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.29 · 2020: $63.10 · 2021: $32.17 · 2022: $113 · 2023: $42.67 · 2024: $18.70 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $198.24 | 2020-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pacira Pharmaceuticals Incorporated | $190.71 | 2019-2025 | Exparel, Zilretta |
| B. Braun Medical INC. | $37.54 | 2019-2022 | |
| Karl Storz Endoscopy-America | $29.27 | 2025 | |
| Octapharma USA, INC. | $22.56 | 2025 | Fibryga |
| Dova Pharmaceuticals | $21.51 | 2019 | |
| Merck Sharp & Dohme LLC | $20.71 | 2025 | Bridion |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.70 | 2024 | Xifaxan |
| Boston Scientific Corporation | $16.05 | 2020 | |
| Mallinckrodt Enterprises LLC | $15.26 | 2019 | |
| Avanos Medical | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Elsass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.